Autovaccines Bacterial vaccines prepared from non-pathogenic, autologous bacteria of human origin. In Eastern Europe they are used in humans to treat chronic inflammatory disorders that are resistant to standard treatments. Worldwide they have veterinary use in all types of infectious disease.
Autovaccines has been studied across 11 research domains including 🛡️ Immunity, 🔬 Oncology, 🫁 Respiratory, ✨ Skin & Hair, 🔬 Inflammation. The primary research focus is 🛡️ Immunity with 23% of studies addressing this area.
This evidence profile for Autovaccines is generated deterministically from 82 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.